Synthesis and Structure−Activity Relationships of Parasiticidal Thiosemicarbazone Cysteine Protease Inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi

Citations Over TimeTop 10% of 2004 papers

Abstract

We have synthesized a library of thiosemicarbazones and screened them against three parasitic cysteine proteases, cruzain, falcipain-2, and rhodesain, and against the respective parasite sources of these three proteases, Trypanosoma cruzi, Plasmodium falciparum, and Trypanosoma brucei. The screens identified compounds that were effective against the enzymes and the parasites but also some compounds that were parasiticidal despite a lack of activity against the proteases. Several compounds were effective in killing all tested parasites. These promising lead compounds were tested for general toxicity in mice, and only one produced observable toxicity after 62 h. Our results suggest that thiosemicarbazones represent validated drug leads that kill several species of protozoan parasites through the inhibition of cysteine proteases as well as other novel targets.

Related Papers

• → Evidence of Trypanosoma cruzi II infection in Colombian chagasic patients(2008)58 cited
• → Discovery and Optimization of a Compound Series Active against Trypanosoma cruzi, the Causative Agent of Chagas Disease(2020)12 cited
• → The reception by French physicians of Chagas' discovery of Trypanosoma cruzi and American trypanosomiasis (1909-1925)(2009)3 cited
• → Discovery and Optimization\nof a Compound Series Active\nagainst <i>Trypanosoma cruzi</i>, the Causative Agent of\nChagas Disease(2020)
• → In Vitro Evaluation of Arylsulfonamide Derivatives against Trypanosoma cruzi(2023)